Abstract
We developed a microelectroporation method for the transfer of genes into neurons in the cerebral cortex of adult rodents, both rats and mice. We selectively expressed either green-fluorescent protein (GFP) or a Ca2+-binding deficient calmodulin (CaM) mutant in the anterior cingulate cortex (ACC). In mice that expressed GFP, positive neuronal cell bodies were found specifically at the injection site in the ACC. Mice that expressed CaM12, a mutant CaM with two impaired Ca2+ binding sites in the N-terminal lobe, exhibited significant changes in vocalization, locomotion, and sensory functions. Long-term potentiation and long-term depression, two major forms of central plasticity, were completely abolished by expression of CaM12. Mice that expressed CaM34, a mutant CaM with two impaired Ca2+ binding sites in the C-terminal lobe, did not show any significant behavioral or electrophysiological alterations. These findings provide strong evidence that CaM is critical for bidirectional synaptic plasticity. This new method will be useful for investigating gene function in specific brain regions of freely moving animals. Furthermore, this approach also may facilitate gene therapy in adult human brains.
- calmodulin
- electroporation
- gene transfer
- anterior cingulate cortex
- synaptic plasticity
- mice
Introduction
Genomic investigations, in both humans and other organisms, have identified numerous genes possibly involved in various brain functions, including development, memory, and drug addiction, as well as various brain disorders. The ability to transfer any gene of interest to a specific brain region in a timely manner would greatly facilitate characterizing the functions of these genes in adult animals and identifying potential therapeutic targets for human diseases. In animals, several approaches have been used to target gene transfer to neurons in vivo, including the use of adenoviral-based vectors (for review, see During and Ashenden, 1998; Costantini et al., 2000; Luo and Saltzman, 2000) and liposomal-plasmid complexes (Schwarze et al., 1999; Shi and Pardridge, 2000). More recently, electroporation, an application of brief electrical pulses to tissue, has been used to temporarily increase cellular permeability to DNA. Electroporation has been successfully used to enhance gene delivery into cells of adult organs, such as skeletal muscle (Aihara and Miyazaki, 1998; Vicat et al., 2000), as well as neurons in the brains of embryonic chicks (Itasaki et al., 1999; Nakamura et al., 2000; Yasuda et al., 2000) and embryonic mice (Fukuchi-Shimogori and Grove, 2001; Saito and Nakatsuji, 2001; Tabata and Nakajima, 2001). Electroporation has also been used to effectively transfer genes into single targeted neurons in brain slices (Haas et al., 2001). However, the use of electroporation to deliver genes into adult mammalian brains has not been reported.
Electroporation in the adult mammalian CNS would provide a valuable method to study various physiological and pathological processes in the mammalian brain. First, it would enable selective delivery of a gene to specific regions of the CNS. Unlike a transgenic approach, it also provides a method for unilateral gene transfer. Second, electroporation in adult brain would provide a way to express a gene at any time during the development of normal or pathophysiological processes. The role of signaling proteins in numerous brain functions, such as the induction and consolidation of memory, the maintenance of persistent pain, cortical reorganization after amputation, or nerve regeneration after injury, could be investigated. This approach also provides a method to rescue behavioral defects in genetically altered mice. Third, electroporation has fewer toxic effects compared with other methods of gene transfer, such as viral gene transfer or the “gene gun” technique. Fourth, transferring the Cre-recombinase gene in mice with a floxed allele may provide a novel tool for generating region-specific gene knock-out mice. Finally, electrozporation may be useful for delivering gene therapy to patients with brain tumors.
In this study, we adapted the electroporation method and showed the expression of both green fluorescent protein (GFP) and mutant calmodulin (CaM) in the anterior cingulate cortex (ACC). This microelectroporation technique will allow selective regional expression of specific genes and proteins in adult mammalian brains.
Materials and Methods
In vivo microelectroporation. cDNA constructs encoding wild-type CaM and mutant CaM12, CaM34, and CaM1234 were transferred from pBF to the mammalian expression vector pJPA7 (Xia et al., 1998). To prepare the DNA for electroporation, the standard molecular procedures were followed. Briefly, after isopranol precipitation, the DNA was fished out with a yellow tip and rinsed in 70% ethanol. Then the DNA was dissolved in Tris-EDTA and precipitated again; these steps were repeated more than three times to obtain highly purified DNA. At the end, the DNA was rinsed in 70% ethanol several times for desalting, dried, and dissolved in double-distilled water to reach the final concentration of 1 μg/μl.
Adult male mice (C57BL/6J; 20-25 gm; The Jackson Laboratory, Bar Harbor, ME) or rats (Sprague Dawley; 280-380 gm; Harlan Sprague Dawley, Indianapolis, IN) were maintained in a temperature- and light-controlled room in an animal facility, with food and water available ad libitum. The animals were anesthetized with 2% halothane and placed in a David Kopf Instruments (Tujunga, CA) stereotaxic apparatus fitted with a mouse adaptor that positioned the skull horizontally between bregma and lambda. DNA was injected into the ACC of mice at the following coordinates: 0.7 mm anterior to bregma, 0.4 mm lateral from the midline, and at a depth of 1.8 mm from the skull surface. A volume of 0.5 μl of concentrated vector (1 × 106 particles/μl) was injected into each site at a rate of 0.05 μl/min using a 30 gauge beveled needle with cannula tubing connected to a Hamilton syringe mounted on a microinjection pump. In most experiments, the ACC was bilaterally injected with GFP (0.5 μl/each side), a mixture of GFP and mutant CaM (1:1 in a volume of 0.5 μl), or enhanced GFP (eGFP) fused in-frame at the N or C terminal of CaM (0.5 μl; n = 8). The needle was left in place for 15 min before being slowly withdrawn. All surgical procedures were performed under sterile conditions and in accordance with Guidelines for the Animal Care and Use approved by the Washington University School of Medicine.
For microelectroporation, square-wave electric pulses were delivered by a Grass Instruments (Quincy, MA) SD9 Stimulator with an isolation unit. A pair of silver electrodes (60 gauge) was placed 3 mm anterior and 2 mm posterior to the injection site, respectively (2.5 mm depth). The silver electrodes were not insulated or chloridized. In preliminary experiments, we tested different electrical parameters for optimal transfection of GFP gene in the ACC. We found the following optimal stimulation paradigms: five pulses delivered at 1 Hz (50 msec duration at 50 V) or a 100 msec train stimulation at 200 Hz (1 msec duration at 20 V). During the electroporation, no motor response was observed. After the gene electroporation, we did not observe any seizure-like activity in animals.
Immunohistochemistry. For immunohistochemical staining, brain sections were prepared on a cryostat and incubated with the following antibodies: polyclonal anti-GFP (1:500; Clontech, Palo Alto, CA) and anti-CaM (1:1000; Chemicon, Temecula, CA), monoclonal anti-mitogen-activated protein (MAP2) (1:500; Chemicon), and anti-glial fibrillary acidic protein (GFAP) (1:500; Chemicon). Goat anti-species antibodies conjugated to Alexa 488 and 568 (1:200-500; both from Molecular Probes, Eugene, OR) were used for immunofluorescent labeling. Terminal deoxynucleotidyl transferase-mediated biotinylated UTP nick end labeling (TUNEL) staining was measured with an in situ cell death detection kit (Roche Molecular Biochemicals, Mannheim, Germany). Brain sections were mounted with Vectashield media (Vector Laboratories, Burlingame, CA) and analyzed by fluorescence microscopy and laser scanning confocal microscopy (Fluowview 2.19; Olympus Optical, Tokyo, Japan). For the DAB reaction, some sections were processed with the Vector ABC kit (Vector Laboratories). CaM expression was quantified on every sixth section by the optical fractionator procedure (Wei et al., 2002). The images were processed using Adobe PhotoShop 5.5 (Adobe Systems, Mountain View, CA). In some experiments, we also used the integrated density to quantify staining results; with the aid of Scion (Frederick, MD) Image program, the intensity of density or the sum of the gray values in the selection, with background subtracted, was computed using the following formula: integrated density = N (number of pixels in the section) × (mean density - background).
Behavioral measurements. Locomotor activity was measured using an open-field activity monitor (43.2 × 43.2 × 30.5 cm; Med Associates, Albans, VT). Each subject was placed in the center of the open field, and activity was measured for 30 min. Ultrasonic vocalizations were detected using four mini-3 ultrasonic detectors (Ultrasound Advice, London, UK), each tuned to a different frequency level ranging from 30 to 120 kHz. The detectors were suspended 19 cm from the floor of the open-field activity monitor. Ultrasonic vocalizations were measured using UltraVox data acquisition software (Noldus, Sterling, VA). The animals' behaviors in the elevated plus maze were measured using an elevated plus maze (Med Associates). The duration of time animals spent in the open arm versus closed arms was recorded. To test acute sensory responses, the latency of response to heating of the tail (tail-flick reflex) or to placement on a hot plate (55°C) was measured as described previously (Wei et al., 2002).
Slice electrophysiology. Transverse slices of the ACC were rapidly prepared and maintained in an interface chamber at 28°C, in which they were subfused with artificial CSF (ACSF) consisting of the following: (in mm) 124 NaCl, 4.4 KCl, 2.0 CaCl2, 1.0 MgSO4, 25 NaHCO3, 1.0 Na2HPO4, and 10 glucose (bubbled with 95% O2 and 5% CO2). Slices were kept in the recording chamber for at least 2 hr before the start of experiments. A bipolar tungsten stimulating electrode was placed in layer V of the ACC, and extracellular field potentials were recorded using a glass microelectrode (3-12 MΩ, filled with ACSF) placed in layer II-III. Five trains of theta burst stimulation (TBS), which consisted of five bursts (four pulses at 100 Hz) of stimuli delivered every 200 msec at the same intensity, were applied to induce long-term potentiation (LTP). A low-frequency, prolonged stimulation (1 Hz, 15 min) was used to induce long-term depression (LTD). Synaptic responses were elicited at 0.02 Hz. In some experiments, intracellular recordings were also performed with glass microelectrodes filled with 2% neurobiotin-2 m potassium chloride (80-200 MΩ). After electrophysiological characterization, cells were injected with neurobiotin (+3.0 nA, 150 msec, 3.3 Hz for 5 min). The slices then fixed in 4% paraformaldehyde 30 min after the injection. Morphological procedures were used to stain and identify the recorded cells.
Data analysis. Results were expressed as mean ± SEM. Statistical comparisons included one- or two-way ANOVA with the post hoc Scheffe F test in immunocytochemical experiments or the Student-Newman-Keuls test in behavioral experiments. In all cases, p < 0.05 was considered to be statistically significant.
Results
We focused on the ACC in this study because of its important role in many higher brain functions (Devinsky et al., 1995; Price, 2000; Allman et al., 2001; Paus, 2001; Peoples, 2002) and because relatively little is known about the essential molecular and cellular signaling mechanisms in this area. To evaluate the possibility of using microelectroporation for neuronal gene transfer in adult animals, we combined a microinjection of naked DNA encoding GFP with local electrical stimulation in the ACC of adult mice under anesthesia (Fig. 1A,B). In preliminary experiments, we tested different electrical parameters (i.e., the frequency and duration of stimulating pulses) to optimize transfection of the GFP gene in the ACC. The optimal stimulation paradigms were found to be either five pulses delivered at 1 Hz (50 msec duration at 50 V) or a 100 msec train stimulation at 200 Hz (1 msec duration at 20 V).
We collected brain samples between 1 and 14 d after the microelectroporation of GFP and performed immunohistochemistry. Three days after the treatment, high levels of GFP expression were found in the ACC (n = 7 mice) (Fig. 2A-C). Because of the expression of GFP in both soma and nerve terminals, we calculated the GFP-positive area as a percentage of the total area of the ACC to estimate the levels of GFP expression. The highest level of GFP expression was usually found within five sections (20 μm thickness) of the injection site (from 58.0 to 99.0%). GFP expression was significantly lower at greater distances (>5 sections) from the injection site (13-29%). We also counted the numbers of GFP-positive cells within each section. We found that that the majority of GFP-positive cells were localized within the ACC (bregma -0.5 to -0.6 mm, mean 21 ± 9 cells per section; bregma +0.5 to +0.6 mm, 376 ± 92 cells per section; and bregma +2.1 to +2.2 mm, 87 ± 30 cells per section; n = 4-5 mice). No GFP-positive staining was detected in the adjacent motor cortex, striatum, lateral septal areas, piriform, prelimbic, or restrosplenial cortices. Furthermore, no GFP expression was detected in related areas, including the somatosensory cortex, hippocampus, thalamus, or periaqueductal gray of the midbrain (Fig. 2A). Thus, the expression of GFP was highly restricted to the injected area. We also performed double staining with the neuronal marker MAP2 or the mircoglia marker GFAP to determine whether GFP expression was localized in neurons or glia within the ACC. We found that GFP was predominantly expressed in neurons. Expression of GFP in microglia was observed at later times (e.g., 14 d) after gene delivery. No GFP expression was detected in mice microinjected with GFP DNA in the absence of electrical stimulation (n = 3 mice).
To determine whether this microelectroporation procedure could also be applied to rats, we performed the same experiments in the ACC of adult rats. Microelectroporation induced high levels of GFP expression in the ACC (n = 5 rats) (Fig. 2D). Similar to the findings in adult mice, GFP expression was highly specific to the ACC, and no immunostaining was detected in other brain areas examined.
One critical issue related to microelectroporation is whether the electrical stimulation itself can induce significant changes in neuronal function or even neuronal death. In our experiments, we used the same electrodes that have been used previously to deliver identical stimulation intensity to brain slices for in vitro experiments. This type of stimulation is not known to cause any type of neuronal injury when delivered at either low or high frequency (1-100 Hz, for durations from a few seconds to 15 min). We used two different methods to further evaluate possible pathological injury attributable to electrical stimulation. First, we used TUNEL staining to label cells undergoing apoptosis (Gavrieli et al., 1992; White et al., 1998). Double staining for GFP and TUNEL revealed no evidence of extensive cell death within the ACC between stimulation electrodes (Fig. 2E). However, TUNEL-positive staining was detected in areas around the tracks of the stimulators, which served as a positive control for TUNEL under these experimental conditions.
We next used sensory and motor behavioral tests to determine whether mice expressing GFP exhibited behavioral alterations compared with sham-treated animals. Mice expressing GFP did not exhibit any sign of behavioral convulsions after the surgery. Similar postoperative changes in body weight were found in sham and GFP-injected mice (sham group, n = 8 mice; GFP expression group, n = 12 mice). In the hot plate test, both groups of animals showed similar escape latencies at two different temperatures (50°C, sham, 30.0 ± 0.5 sec; GFP, 28.8 ± 1.0 sec; 55°C, sham, 13.2 ± 0.4 sec; GFP, 13.7 ± 0.7 sec). We also measured the locomotor activity of mice in an open-field chamber. No significant differences were found between the two groups during a 30 min observation time (data not shown). Thus, microelectroporation can be used to selectively express a gene in a selected brain area without inducing major behavioral side effects.
To determine whether microelectroporation of a mammalian signaling gene can induce physiological and behavioral changes in rodents, we expressed a mutant CaM protein in the ACC. CaM is a ubiquitous and highly conserved Ca2+-binding protein. As a major Ca2+-signaling mediator, CaM plays a critical role in numerous vital physiological functions, including fertilization, cell proliferation, development, and learning and memory (Cyert, 2001; Hoeflich and Ikura, 2002; Saimi and Kung, 2002). CaM regulates various intracellular protein kinases and phosphatases in response to increases in intracellular Ca2+ levels attributable to activation of membrane receptors (e.g., NMDA receptors) or opening of ion channels (e.g., L-type voltage-gated calcium channels). CaM target proteins, such as Ca2+/CaM-dependent protein kinase II (CaMKII), CaM-activated adenylyl cyclases, and the CaM-activated phosphatase calcineurin, are known to be important for synaptic plasticity and behavioral learning and memory (Malenka and Nicoll, 1999; Kandel, 2001; Lisman et al., 2002). Recent genetic studies have consistently demonstrated that CaM-dependent protein kinases and phosphatases play important roles in synaptic plasticity, such as long-term potentiation and depression, as well as cognitive functions (Silva et al., 1998; Malenka and Nicoll, 1999; Kandel, 2001; Lisman et al., 2002). Genetic studies of CaM have proven to be more difficult than studies of its target proteins. No natural CaM mutant has ever been found. CaM point mutations have been generated, but these have only been studied in yeast, Paramecium, and Drosophila (Hinrichsen et al., 1986; Ohya and Bostein, 1994; Nelson et al., 1997). CaM null mutants in these species are lethal (Davis et al., 1986; Heiman et al., 1996), and survival of CaM knock-out mice has not been reported.
Four calcium-binding sites have been identified on the two lobes of CaM. Electrophysiological studies using Xenopus oocytes or HEK293 cells showed that impairment of the Ca2+ binding sites on each of the two lobes of CaM specifically disrupted the function or unique features of potassium and calcium channels (Xia et al., 1998; DeMaria et al., 2001). Fewer studies have attempted to identify physiological roles of the Ca2+-binding EF hands of CaM in the CNS. Next, we microinjected DNA encoding either wild-type CaM or CaM with mutations in two or four of the Ca2+-binding EF hands (CaM12, CaM34, or CaM1234) (Fig. 3A) into the ACC of adult mice. In preliminary experiments, we found that Western blots did not show any obvious changes in CaM protein levels in ACC slices (data not shown). It is possible that Western blotting may not be sufficiently sensitive to detect changes in CaM levels in selected ACC cells. Thus, we next used immunohistochemistry to determine whether changes in CaM-like activity could be detected within certain areas of the ACC. Using this approach, we found that unilateral injection of mutant CaM caused an obvious increase in CaM immunoreactivity specifically in the targeted ACC (integrated density, 10.7 ± 1.7; n = 5) relative to that of the contralateral side (1.4 ± 0.3) (Fig. 3B,C). To further verify the expression of recombinant CaM in the ACC, we used eGFP fused in-frame at the N or C terminal of CaM. With in-frame fusion at the N terminal of CaM, we found that GFP-positive ACC cells expressed stronger immunostaining for CaM (n = 8) (Fig. 3D). Fusions at the C-terminal of CaM with eGFP did not result in significant expression of either GFP or CaM (data not shown).
Costaining with selective neuronal and glial markers showed that the majority of CaM staining was localized within ACC neurons 3 d after microelectroporation (Fig. 3E). The expressed mutant CaM was found primarily within the cytoplasm and not in nuclei, which is consistent with the fact that CaM is mainly expressed in the cytoplasm under resting conditions (Deisserorth et al., 1998; Wei et al., 2002).
To further determine whether the mutant CaM was effectively expressed in the ACC, we performed various behavioral experiments to see whether mice overexpressing mutant CaM exhibited any abnormal behavior patterns. The ACC and related prefrontal cortex are known to play roles in at least three major physiological functions: emotion-related activity, such as vocalization, locomotor functions, and sensory perception, including pain (Devinsky et al., 1995; Rainville et al., 1997; Hutchison et al., 1999; Price, 2000; Allman et al., 2001; Paus, 2001; Wei and Zhuo, 2001; Peoples, 2002; Zhuo, 2002). To determine whether expression of the various mutant forms of CaM altered the animals' behavior and to identify possible functional roles of the four Ca2+ binding sites in CaM, we first evaluated ultrasonic vocalization of mice in an open-field chamber. Vocalization is widely used for communication between animals and serves as an index for various emotional states, including injury, defense, escape, and pleasure. Previous studies suggested that the ACC plays an important role in vocalization related to emotion and anxiety in humans and animals (Smith, 1945; Allman et al., 2001). We hypothesized that disruption of the Ca2+/CaM-dependent signaling pathway may affect ACC function by altering vocalization behavior in mice expressing the CaM mutants.
Among the various mutants, we found that expression of CaM12 in the ACC significantly enhanced spontaneous ultrasonic vocalization activity (n = 12 mice) (Fig. 4A). The total duration of vocalization during a 30 min period was significantly higher in CaM12 mice (20.7 ± 4.9 sec) compared with control GFP mice (5.3 ± 2.6 sec; p < 0.001) (Fig. 4A). The effect of CaM12 on vocalization was frequency dependent, with the greatest increase displayed at 30 and 50 kHz. The total number of ultrasonic events was also significantly increased in CaM12 mice (Fig. 4A). No significant differences were found between the CaM34 or CaM1234 mice and control groups, suggesting that these effects on vocalization are relatively selective for the CaM12 mutant. As an additional test for emotion, we also measured animals' behaviors in the elevated plus maze and found no significant difference between control GFP (n = 7) and CaM12 (n = 5) mice.
Second, we measured locomotor activity in control and mutant CaM mice. Whereas the average moving velocity of mice was not significantly different in any of the mutant CaM mice compared with controls (n = 4-12 mice) (Fig. 4B), the total distance traveled was higher in mice expressing CaM12 or CaM1234 (n = 4-12 mice) (Fig. 4B). Mice expressing the CaM12 or CaM1234 mutants spent less time at rest and more time being ambulatory compared with GFP-expressing control mice (Fig. 4B). No such differences were observed in mice expressing CaM34.
Finally, we performed three different sensory tests and found that CaM12, but not CaM34 or CaM1234, caused significant changes in the hot plate response to noxious heat. Mice expressing CaM12 in the ACC were less sensitive to noxious stimulation in the hot plate test (Fig. 4C). No changes in the tail-flick reflex or the hindpaw mechanical withdrawal thresholds were found, except that CaM1234 expression also caused changes in tail-flick response latencies (Fig. 4C).
The behavioral findings described above clearly indicate that expression of mutant CaM can cause significant changes in ACC-related physiological functions. To determine whether mutant CaM also induces changes at the synaptic level, we performed electrophysiological experiments to evaluate neuronal membrane excitability and synaptic plasticity in the ACC. First, considering the important role of CaM-dependent protein kinases and phosphatases in synaptic plasticity, we studied potential changes in synaptic responses to repetitive TBS. Electrophysiological recordings from animals and humans have revealed that ACC neurons are likely to fire action potentials at 4-7 Hz (theta) during various behavioral tests (Smith, 1945; Gevins et al., 1997; Hutchison et al., 1999; Suetsugi et al., 2000). We therefore performed electrophysiological experiments in ACC slices from control and CaM mutant mice. Similar to previous studies in normal brain slices (Wei et al., 2002), TBS caused significant synaptic potentiation in ACC slices from mice subjected to microelectroporation, and the enhanced responses lasted for at least 45 min in GFP-expressing slices (n = 6 slices from 4 mice) (Fig. 5A). This finding is consistent with the behavioral observations that expression of GFP alone did not cause any significant changes in ultrasonic vocalization or locomotor activity of mice. In contrast to the findings in GFP-expressing mice, the TBS-induced potentiation was completely absent in slices from GFP-CaM12 mice (n = 9 slices from 6 mice; mean of 100.1 ± 14.4% relative to baseline) (Fig. 5A). No obvious differences in baseline field synaptic responses were detected (n = 18 slices from 10 mice for GFP mice; n = 16 slices from 9 mice for GFP-CaM12 mice). We also measured LTP in GFP-CaM34 and GFP-CaM1234 mice. In brain slices from GFP-CaM34 mice, a long-lasting enhancement of synaptic responses was observed (n = 5 slices from 3 mice; mean of 143.2 ± 6.8%) (Fig. 5B). However, in slices from GFP-CaM1234 mice, TBS induced no significant potentiation (n = 6 slices from 4 mice; mean of 105.7 ± 24.1%).
LTD, which can be induced by repetitive low-frequency stimulation, has been reported to occur in many brains regions, including the ACC (Wei et al., 1999). We also examined whether the expression of mutant CaMs had any effect on LTD. Whereas 1 Hz stimulation (for 15 min) significantly reduced synaptic responses in ACC slices from mice that received GFP injections (n = 6 slices from 4 mice; mean of 69.1 ± 12.6%) (Fig. 5C), no such depression was detected in ACC slices from GFP-CaM12 mice (n = 5 slices from 3 mice; mean of 105.1 ± 7.8%) (Fig. 5C). In contrast, 1 Hz stimulation (15 min) readily induced LTD in slices obtained from GFP-CaM34 mice (n = 5 slices from 3 mice; mean of 66.3 ± 19.1%) or GFP-CaM1234 mice (n = 6 slices from 5 mice; mean of 81.1 ± 6.1%) (Fig. 5D). To measure possible changes at other stimulation frequencies, we applied the same number of pulses at two other frequencies (5 and 10 Hz). Again, no significant differences were found among control and mutant groups at both testing frequencies (n = 4-7 slices from at least 3 mice per group) (Fig. 6).
These studies demonstrate that CaM12 caused changes in several parameters of behavior and synaptic plasticity. Thus, we next asked whether CaM12 expression alters the neuronal spiking properties of ACC neurons. To do this, we made intracellular recordings from GFP-expressing cells under a fluorescence microscope (Fig. 7A-C). No significant changes were observed in neuronal spiking in response to direct current injection. Similarly, resting membrane potentials were identical between cells recorded from control GFP (n = 10) and GFP-CaM12 (n = 6) brain slices. Furthermore, the current threshold for eliciting the first spike was similar in control and mutant slices (n = 3 cells for each group), and the number of spiking induced by injection of 0.3 nA was also identical (n = 6-10 cells). These results indicate that CaM12 expression did not cause any major changes in the intrinsic neuronal electrophysiological properties of ACC neurons.
Discussion
Through the use of microelectroporation, we showed that it is possible to overexpress a gene in a specific brain region of adult rats and mice. Our findings provide strong physiological evidence that ACC neurons contribute to specific motor and sensory functions, which is consistent with previous studies in humans. The overexpression of a CaM mutant with impaired Ca2+ binding to the N-terminal lobe in the ACC of mice significantly altered ultrasonic vocalization, locomotor activity in an open field, and sensory responses to noxious heat applied to the hindpaw. Because the mutant CaM includes changes in only two of the Ca2+ binding sites within CaM, these results suggest that the fine regulation of Ca2+/CaM signaling pathways play important roles in ACC-related physiological functions. Although our results consistently indicate that the Ca2+-binding sites of the CaM N-terminal (CaM12) lobe are functionally important, the contribution of Ca2+ binding sites of the CaM C-terminal (CaM34) lobe for ACC-related behavioral responses remain uncertain. Clearly, the Ca2+ binding sites of the CaM C-terminal (CaM34) lobe play different roles in ACC-related functions and in the functions of potassium channels and P/Q-type Ca2+ channels (Xia et al., 1998; DeMaria et al., 2001). Because of limitation in the sensitivity of our biochemical assays, we do not know the exact amount of the expression of CaM12, CaM34, and CaM1234 in the ACC. Future studies are needed to address the exact mechanism contributing to their physiological effects.
CaM is thought to be the key molecule for controlling synaptic changes, in terms of both potentiation and depression (Malenka and Nicoll, 1999; Kandel, 2001; Lisman et al., 2002). It is hypothesized that, although high Ca2+ levels lead to synaptic potentiation, moderate increases in Ca2+ levels lead to short-term potentiation or long-term depression of synaptic transmission. Inhibition of NMDA receptors or L-type voltage-gated calcium channels, which are key membrane receptors and channels for Ca2+ influx during periods of high synaptic activity, blocked both synaptic potentiation and depression in many brain regions (Bear, 1996; Malenka and Nicoll, 1999; Wei et al., 1999). In the present studies, we found that expression of CaM12 in the ACC blocked TBS-induced LTP. Previous studies using mice that lack CaMKIV, a key protein kinase downstream of CaM, showed that CaMKIV is critical for synaptic potentiation in the ACC (Wei et al., 2002). Together, these results strongly suggest that calcium/CaM-dependent signaling pathways play an important role in LTP in the ACC. In addition to synaptic potentiation, it has been hypothesized that CaM also serves as a key sensor for synaptic depression triggered by changes in the magnitude or dynamics of increases in postsynaptic Ca2+ (Lisman, 1989; Bear, 1996), although there is no direct evidence that CaM is involved. In the ACC, low-frequency stimulation produced LTD of synaptic responses, and activation of both L-type voltage-gated calcium channels and metabotropic glutamate receptors are required for the induction of LTD in the ACC (Wei et al., 1999). Here, we found that ACC LTD was blocked in CaM12-expressing mice. Our present results provide strong evidence that CaM serves as a key signaling protein in bidirectional synaptic plasticity in the ACC. Furthermore, we also show, for the first time, that the first two Ca2+ binding sites on the CaM N-terminal lobe are essential for both LTP and LTD. Although synaptic plasticity was significantly altered, we did not observe any significant changes in soma excitability, such as the generation of action potentials in response to injected currents. It is quite possible that a more complete elimination of CaM would cause more pronounced changes in neuronal properties such as spiking.
It is important to point out that there are certain limitations related to the mechanisms by which mutant CaM induces these alterations. First, it is not known how mutant CaM affects downstream signaling pathways. Many protein kinases and phosphatases are regulated by CaM, and additional experiments are clearly needed to determine how expression of mutant CaM may affect their activities. Second, we used the synaptic model of plasticity to study changes in CaM-dependent synaptic plasticity. We believe that changes in LTP-LTD cannot completely explain the changes observed in various behaviors. At the moment, it is also unclear how and if LTP and/or LTD contribute to behavioral changes such as sensory responses and ultrasonic vocalization. Because of the incomplete understanding of the cellular and molecular mechanisms involved in ACC function, more work will be needed to clarify these issues. Third, we would like to point out that overexpression of CaM12 and CaM1234 shared some features, but there were also distinct effects of the two mutants. In all three measurements of locomotor activity, CaM12 overexpression had effects similar to CaM1234 overexpression. However, in the hot plate test, overexpression of CaM12, but not CaM1234, significantly increased behavioral response latencies. At the synaptic level, overexpression of CaM12 or CaM1234 blocked LTP in the ACC. However, LTD was only blocked by expression of CaM12 and not CaM1234. These results suggest that the various Ca2+ binding sites on CaM may have specific roles in neurons.
This study is the first to show that microelectroporation can be used to express a gene in the adult mammalian brain. Unlike current transgenic approaches, microelectroporation permits overexpression of a gene within a highly specific brain region, either unilaterally or bilaterally. In combination with gene knock-out techniques, this approach can serve as a useful tool to study the molecular mechanisms underlying higher brain functions in adult animals. This may provide a new method for gene therapy in adult human brains.
Footnotes
- Received February 4, 2003.
- Revision received July 16, 2003.
- Accepted July 16, 2003.
This work was supported by National Institute of Neurological Disorders and Stroke Grant 38680, National Institute on Drug Abuse Grant 10833, the McDonnell Center for Higher Brain Function at Washington University, and the EJLB-Canadian Institutes of Health Research Michael Smith Chair in Neurosciences and Mental Health. We thank Drs. Louis J. Muglia, Yi Rao, and Zhou-Feng Chen for helpful suggestions. Proofreading and editing were provided by Dr. Dana Beitner-Johnson at BiomedEditors (Cincinnati, OH).
Correspondence should be addressed to either of the following: Dr. Min Zhuo, Department of Physiology, 1 King's College Circle, University of Toronto, Toronto, Canada, M5S 1A8, E-mail: min.zhuo{at}utoronto.ca; or Dr. Feng Wei, Department of Oral and Craniofacial Biological Sciences, University of Maryland Dental School, 666 West Baltimore Street, Baltimore, MD 21201, E-mail: fwei001{at}umaryland.edu.
Copyright © 2003 Society for Neuroscience 0270-6474/03/238402-08$15.00/0